Inogen, Inc. (INGN)
USD 6.84
(-2.98%)
USD 6.84
(-2.98%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 315.66 Million USD | -16.32% |
| 2022 | 377.24 Million USD | 5.37% |
| 2021 | 358 Million USD | 16.05% |
| 2020 | 308.48 Million USD | -14.77% |
| 2019 | 361.94 Million USD | 1.07% |
| 2018 | 358.11 Million USD | 43.57% |
| 2017 | 249.43 Million USD | 22.98% |
| 2016 | 202.82 Million USD | 27.56% |
| 2015 | 159 Million USD | 41.29% |
| 2014 | 112.53 Million USD | 49.17% |
| 2013 | 75.44 Million USD | 55.31% |
| 2012 | 48.57 Million USD | 58.57% |
| 2011 | 30.63 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 78.02 Million USD | 2.81% |
| 2024 Q2 | 88.76 Million USD | 13.76% |
| 2023 FY | 315.66 Million USD | -16.32% |
| 2023 Q4 | 75.89 Million USD | -9.61% |
| 2023 Q3 | 83.96 Million USD | 0.4% |
| 2023 Q2 | 83.63 Million USD | 15.9% |
| 2023 Q1 | 72.16 Million USD | -18.08% |
| 2022 Q1 | 80.38 Million USD | 5.21% |
| 2022 Q3 | 105.38 Million USD | 1.95% |
| 2022 Q2 | 103.37 Million USD | 28.6% |
| 2022 FY | 377.24 Million USD | 5.37% |
| 2022 Q4 | 88.09 Million USD | -16.41% |
| 2021 Q1 | 86.93 Million USD | 17.51% |
| 2021 Q2 | 101.56 Million USD | 16.83% |
| 2021 FY | 358 Million USD | 16.05% |
| 2021 Q3 | 93.1 Million USD | -8.33% |
| 2021 Q4 | 76.4 Million USD | -17.94% |
| 2020 Q4 | 73.97 Million USD | -0.47% |
| 2020 FY | 308.48 Million USD | -14.77% |
| 2020 Q3 | 74.32 Million USD | 3.68% |
| 2020 Q2 | 71.69 Million USD | -18.98% |
| 2020 Q1 | 88.48 Million USD | 12.13% |
| 2019 Q1 | 90.2 Million USD | 4.24% |
| 2019 FY | 361.94 Million USD | 1.07% |
| 2019 Q4 | 78.91 Million USD | -14.0% |
| 2019 Q3 | 91.76 Million USD | -9.2% |
| 2019 Q2 | 101.06 Million USD | 12.04% |
| 2018 Q4 | 86.53 Million USD | -9.19% |
| 2018 FY | 358.11 Million USD | 43.57% |
| 2018 Q3 | 95.29 Million USD | -2.0% |
| 2018 Q2 | 97.23 Million USD | 23.01% |
| 2018 Q1 | 79.05 Million USD | 23.93% |
| 2017 FY | 249.43 Million USD | 22.98% |
| 2017 Q1 | 52.5 Million USD | 3.24% |
| 2017 Q2 | 64.12 Million USD | 22.14% |
| 2017 Q3 | 69.03 Million USD | 7.66% |
| 2017 Q4 | 63.78 Million USD | -7.6% |
| 2016 FY | 202.82 Million USD | 27.56% |
| 2016 Q1 | 42.98 Million USD | 6.29% |
| 2016 Q3 | 54.42 Million USD | -0.27% |
| 2016 Q4 | 50.85 Million USD | -6.56% |
| 2016 Q2 | 54.56 Million USD | 26.93% |
| 2015 Q2 | 44.02 Million USD | 30.45% |
| 2015 Q4 | 40.44 Million USD | -0.81% |
| 2015 Q3 | 40.77 Million USD | -7.38% |
| 2015 Q1 | 33.75 Million USD | 15.91% |
| 2015 FY | 159 Million USD | 41.29% |
| 2014 Q4 | 29.11 Million USD | -0.94% |
| 2014 Q2 | 30.39 Million USD | 28.6% |
| 2014 Q1 | 23.63 Million USD | 19.59% |
| 2014 Q3 | 29.39 Million USD | -3.29% |
| 2014 FY | 112.53 Million USD | 49.17% |
| 2013 Q1 | 15.74 Million USD | 13.77% |
| 2013 Q2 | 20.15 Million USD | 28.01% |
| 2013 FY | 75.44 Million USD | 55.31% |
| 2013 Q4 | 19.76 Million USD | -0.08% |
| 2013 Q3 | 19.77 Million USD | -1.89% |
| 2012 Q4 | 13.84 Million USD | 5.25% |
| 2012 Q3 | 13.15 Million USD | 0.0% |
| 2012 FY | 48.57 Million USD | 58.57% |
| 2011 FY | 30.63 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -2517.63% |
| BrainsWay Ltd. | 31.78 Million USD | -893.11% |
| Cerus Corporation | 156.36 Million USD | -101.871% |
| Envoy Medical, Inc. | 316 Thousand USD | -99792.405% |
| electroCore, Inc. | 16.03 Million USD | -1869.183% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -48915.528% |
| IceCure Medical Ltd | 3.22 Million USD | -9675.782% |
| OrthoPediatrics Corp. | 148.73 Million USD | -112.234% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -12900.824% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -86382.429% |
| MaxCyte, Inc. | 41.28 Million USD | -664.532% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -16067.454% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -284925.463% |
| Orthofix Medical Inc. | 746.64 Million USD | 57.723% |
| PAVmed Inc | 2.45 Million USD | -12773.573% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -1301.75% |
| RxSight, Inc. | 89.07 Million USD | -254.368% |
| Sight Sciences, Inc. | 81.05 Million USD | -289.434% |
| SI-BONE, Inc. | 138.88 Million USD | -127.28% |
| TELA Bio, Inc. | 58.45 Million USD | -440.024% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -68.696% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -2187.226% |
| Acutus Medical, Inc. | 7.16 Million USD | -4306.198% |
| Talis Biomedical Corporation | 412 Thousand USD | -76516.505% |
| Spectral AI, Inc. | 18.05 Million USD | -1648.228% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -3086.875% |
| CVRx, Inc. | 39.29 Million USD | -703.308% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -32485.738% |
| Bioventus Inc. | 512.34 Million USD | 38.389% |
| Venus Concept Inc. | 76.35 Million USD | -313.416% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -1605.256% |
| LivaNova PLC | 1.15 Billion USD | 72.636% |
| 908 Devices Inc. | 50.22 Million USD | -528.442% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 34.546% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -409613.93% |
| NeuroPace, Inc. | 65.42 Million USD | -382.506% |
| LENSAR, Inc. | 42.16 Million USD | -648.648% |
| Apyx Medical Corporation | 52.34 Million USD | -502.991% |
| Cutera, Inc. | 212.36 Million USD | -48.638% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -846.28% |
| BioSig Technologies, Inc. | 18 Thousand USD | -1753566.667% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -89.401% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -1217.721% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 79.524% |
| Axonics, Inc. | 366.37 Million USD | 13.843% |
| Outset Medical, Inc. | 130.37 Million USD | -142.115% |
| IRIDEX Corporation | 51.86 Million USD | -508.572% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -131.777% |
| IRadimed Corporation | 65.56 Million USD | -381.466% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -26741.837% |
| INVO Bioscience, Inc. | 3.02 Million USD | -10350.328% |
| Telesis Bio, Inc. | 27.5 Million USD | -1047.479% |
| Viemed Healthcare, Inc. | 183 Million USD | -72.484% |
| Varex Imaging Corporation | 811 Million USD | 61.078% |
| Quipt Home Medical Corp. | 221.74 Million USD | -42.355% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -359.643% |
| Dynatronics Corporation | 32.53 Million USD | -870.248% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -3537.474% |
| Semler Scientific, Inc. | 68.18 Million USD | -362.953% |
| InMode Ltd. | 492.04 Million USD | 35.848% |
| Bruker Corporation | 2.96 Billion USD | 89.352% |
| Cytosorbents Corporation | 36.34 Million USD | -768.405% |
| DexCom, Inc. | 3.62 Billion USD | 91.286% |
| Align Technology, Inc. | 3.86 Billion USD | 91.827% |
| Viveve Medical, Inc. | 6.42 Million USD | -4812.232% |
| ZimVie Inc. | 457.43 Million USD | 30.993% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -63.542% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -284925.463% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 57.784% |
| Profound Medical Corp. | 7.33 Million USD | -4205.812% |
| Insulet Corporation | 1.69 Billion USD | 81.4% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -150.369% |
| iCAD, Inc. | 17.31 Million USD | -1722.728% |
| Nuwellis, Inc. | 8.86 Million USD | -3461.146% |
| Biotricity, Inc. | 12.06 Million USD | -2516.687% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 35.93% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -4987.188% |
| PAVmed Inc. | 2.45 Million USD | -12773.573% |
| BIOLASE, Inc. | 49.16 Million USD | -542.055% |
| Beyond Air, Inc. | 1.15 Million USD | -27135.548% |
| FONAR Corporation | 102.88 Million USD | -206.811% |
| AxoGen, Inc. | 159.01 Million USD | -98.513% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -15.027% |
| Inari Medical, Inc. | 493.63 Million USD | 36.054% |
| UFP Technologies, Inc. | 400.07 Million USD | 21.099% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -1696996.774% |
| Tenon Medical, Inc. | 2.92 Million USD | -10680.738% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -4533.856% |
| AdaptHealth Corp. | 3.2 Billion USD | 90.136% |
| Sintx Technologies, Inc. | 2.62 Million USD | -11915.988% |
| NanoVibronix, Inc. | 2.28 Million USD | -13726.544% |
| Quanterix Corporation | 122.36 Million USD | -157.96% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -1193.423% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -57.42% |
| TransMedics Group, Inc. | 241.62 Million USD | -30.642% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -2178.476% |
| NeuroMetrix, Inc. | 5.9 Million USD | -5248.878% |
| Hyperfine, Inc. | 11.03 Million USD | -2761.313% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -91.134% |
| Biomerica, Inc. | 5.41 Million USD | -5729.363% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -524.315% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -78.204% |